Advanced Technologies for Disease Intervention
Innovations Across Precision Medicine, Nutrition and Holistic Therapies
- 1st Edition - October 1, 2026
- Latest edition
- Editors: Ranbir Chander Sobti, Aastha Sobti, Jagmohan Singh, Harpal S. Buttar
- Language: English
Advanced Technologies for Disease Intervention: Innovations Across Precision Medicine, Nutrition and Holistic Therapies, Two Volume Set investigates current and emerging advanc… Read more
Description
Description
Advanced Technologies for Disease Intervention: Innovations Across Precision Medicine, Nutrition and Holistic Therapies, Two Volume Set investigates current and emerging advances in disease detection, diagnosis, treatment and prevention, and how molecular medicine and biotechnology have contributed to this changing landscape. Volume One focuses on sustainable health practices through biotechnology, exploring traditional health systems, diagnostic innovations, and integrative therapies. Key topics include: the role of traditional medicine and practices in sustainable health; contemporary and emerging technologies such as aptamer diagnostics, telemedicine, nanomaterials and AI in healthcare, and much more.
Volume Two then delves deeper into emerging technologies for disease intervention, focusing on drug development, delivery systems, nutrition, and natural products for health. Themes explored here include: developments and trends in drug discovery; drug repurposing; contemporary drug delivery systems; phototherapeutics; personalized drug delivery; innovations in vaccine development; the role of nutraceuticals in disease prevention; and the use of natural products and herbal interventions for sustainable health.
Volume Two then delves deeper into emerging technologies for disease intervention, focusing on drug development, delivery systems, nutrition, and natural products for health. Themes explored here include: developments and trends in drug discovery; drug repurposing; contemporary drug delivery systems; phototherapeutics; personalized drug delivery; innovations in vaccine development; the role of nutraceuticals in disease prevention; and the use of natural products and herbal interventions for sustainable health.
Key features
Key features
- Provides an in-depth compendium of emerging biotechnological therapies and diagnostic innovations, covering the latest advances in molecular medicine and biopharmaceutical research
- Delivers interdisciplinary perspectives, fostering collaboration across various research fields to enhance patient care strategies
- Considers both traditional therapies and cutting-edge innovations in the pursuit of sustainable health, from yoga practices, nutraceuticals and natural supplements, to AI, regenerative medicine, recombinant antigens, and genome editing technologies
Readership
Readership
Researchers working across various biomedical fields, including biotechnology, molecular biology, the pharmaceutical and nutraceutical sectors
Table of contents
Table of contents
VOLUME 1: INTEGRATING MODERN HEALTH TECHNOLOGIES AND TRADITIONAL THERAPIES TO PROMOTE GOOD HEALTH
SECTION 1: BIOTECHNOLOGICAL INNOVATIONS FOR SUSTAINABLE DEVELOPMENT TOWARDS GOOD HEALTH CARE SYSTEM
1. ADVANCED TECHNOLOGIES FOR DISEASE INTERVENTION: INNOVATIONS ACROSS PRECISION MEDICINE
2. EMERGING APTAMER DIAGNOSTICS: NEXT GEN POINT-OF-CARE (POC) TECHNOLOGY
3. ROLE OF APTAMERS IN MOLECULAR MEDICINE
4. CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR) AND BEYOND: REVOLUTIONIZING PRECISION MEDICINE AND GENETIC THERAPIES
5. BIOSIMILARS IN CONTEMPORARY MEDICINE: FROM MOLECULAR DESIGN TO GLOBAL CLINICAL TRANSLATION
6. SWEET SITE OF RNA : DISCOVERY AND IMPLICATION OF GLYCO RNA IN HEALTH AND DISEASE
7. THE ROLE OF ER STRESS IN DISEASE AND IN THERAPEUTIC INTERACTION
SECTION 2: POTENTIAL OF STEM CELLS AND REGENERATIVE MEDICINE
8. ADULT STEM CELLS AND APPLICATIONS
9. EMBRYONIC STEM CELL RESEARCH: SCIENTIFIC ADVANCES AND BIOETHICAL CHALLENGES
10. ORGANOIDS AND LAB-GROWN TISSUES: A NEW FRONTIER IN DISEASE MODELING AND REGENERATIVE MEDICINE
11. 3D BIOPRINTING AND TISSUE ENGINEERING: BUILDING THE FUTURE OF TRANSPLANTATION
12. ADVANCEMENTS IN HUMAN-BASED BIOMATERIALS FOR 3D BIOPRINTING TECHNOLOGIES
13. POTENTIAL ROLE OF 3D-BIOPRINTING OF RECAPITULATED ORGANS AND TISSUES IN MODERN MEDICINE: AN OVERVIEW OF CARDIOVASCULAR DISEASES, CANCER, AND NON-CANCER APPLICATIONS
SECTION 3: ARTIFICIAL INTELLIGENCE & MACHINE LEARNING IN HEALTHCARE
14. ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN MICROBIAL DECIPHERING
15. ARTIFICIAL INTELLIGENCE IN CLINICAL DIAGNOSTICS AND DECISION MAKING
16. MODELING AND PREDICTING TO UNDERSTAND INFECTIOUS DISEASE TRANSMISSION
17. THE FUTURE OF HEALING: AI-DRIVEN PRECISION MEDICINE FOR PERSONALIZED HEALTH CARE
18. MOLECULAR EPIDEMIOLOGICAL APPROACH IN DISEASE MANAGEMENT
SECTION 4: MOLECULAR INSIGHTS AND ADVANCED THERAPEUTICS IN DISEASE MANAGEMENT
19. MAPPING MECHANISMS OF METASTASIS AND METABOLISM: ADVANCES IN UNDERSTANDING THE COMPLEXITY OF THETUMOR MICROENVIRONMENT
20. MOLECULAR PATHOPHYSIOLOGY OF STROKE: MECHANISTIC INSIGHTS, BIOMARKERS, AND EMERGING THERAPEUTIC TARGETS
21. PHARMACOTHERAPY OF HEART FAILURE: CURRENT TRENDS AND FUTURE DIRECTIONS
22. MOLECULAR INTERVENTIONS IN HEART FAILURE: GENE EDITING AND GENE THERAPY
23. ARRHYTHMIA-INDUCED SUDDEN CARDIAC DEATH: INSIGHTS AND PROSPECTS ON PATHOPHYSIOLOGY, BIOMARKERS, AND THERAPEUTIC STRATEGIES
24. ADVANCED STRATEGIES FOR DETECTION AND TREATMENT OF HIGH-RISK ATHEROSCLEROTIC PLAQUES: THE ROLE OF SINGLE-CELL RNA SEQUENCING
SECTION 5: NANOTECHNOLOGY AND BIOMATERIALS IN MODERN MEDICINE
25. PIONEERING ALZHEIMER'S DISEASE THERAPIES: INSIGHTS INTO PRECISION MEDICINE, NANOTHERAPEUTICS, AND STEM CELL INNOVATIONS
26. EVOLVING PARADIGMS IN ALZHEIMER'S DISEASE: FROM PATHOGENESIS TO PRECISION THERAPIES
SECTION 6: MICROBIOME, MENTAL HEALTH, AND INTEGRATIVE DISEASE MANAGEMENT
27. MICROBIOME MEDICINE: THE GUT-IMMUNE-BRAIN AXIS IN HEALTH AND DISEASE
28. THE CRUCIAL ROLES OF GUT MICROBIOTA IN THE DEVELOPMENT OF NON-COMMUNICABLE DISEASES WITH SPECIAL FOCUS ON THE EFFICACY OF PROBIOTICS AND BOVINE COLOSTRUM IN THE MANAGEMENT OF GASTROINTESTINAL DISORDERS IN ADULTS AND CHILDREN
29. THE PATHOPHYSIOLOGICAL RELATIONSHIP BETWEEN DIABETES MELLITUS AND ALZHEIMER’S DISEASE AND MANAGEMENT WITH HERBAL REMEDIES: AN OVERVIEW OF PRECLINICAL AND CLINICAL STUDIES.
30. EPIGENOME, NUTRIGENOME: IMPLICATIONS IN EVOLUTION OF TYPE 2 DIABETES
31. INSIGHTS INTO THE COMPLEXITIES OF DEMENTIA: DIAGNOSIS, THERAPEUTICS AND CURRENT RESEARCH
32. COGNITIVE DECLINE AND DEMENTIA IN ELDERLY HUMANS: HOLISTIC APPROACHES FOR THE PREVENTION AND MANAGEMENT OF NEURODEGENERATIVE DISEASES AND PSYCHIATRIC DISORDERS
33. REVOLUTIONIZING DENTAL CARE: A NEW ERA OF PRECISION, PERSONALIZATION, AND INNOVATION
34. OSTEOPOROSIS AS A PUBLIC HEALTH PROBLEM
35. INTEGRATIVE MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) THROUGH YOGIC INTERVENTIONS
36. CHALLENGES IN THE EARLY DIAGNOSIS OF RESPIRATORY DISEASES AND POSSIBLE INTERVENTIONS
37. PRECISION MEDICINE IN ACUTE AND CHRONIC PANCREATITIS
38. KIDNEY DISEASE – INNOVATIONS AND SOLUTIONS
39. PATHOPHYSIOLOGY OF CHRONIC KIDNEY DISEASE: EPIDEMIOLOGY, DIAGNOSTICBIOMARKERS, AND MANAGEMENT WITH PROBIOTICS AND PREBIOTICS
40. CURRENT TRENDS AND CHALLENGES IN REPRODUCTIVE HEALTH ACROSS GENDERS
41. MALE BREAST CANCER: RARELY KNOWN DISEASE
RANBIR C. SOBTI SR. AND JAGMOHAN SINGH
VOLUME 2: STRATEGIES FOR COMBATING DISEASES THROUGH NEW THERAPEUTICS, DRUG DEVELOPMENT, NUTRITIONAL APPROACHES, NUTRITION, AND HOLISTIC THERAPIES
SECTION 1: INNOVATIONS IN DRUG DISCOVERY, DELIVERY SYSTEMS, AND REPURPOSING
42. CARRAGEENAN AND FUCOIDAN-BASED DELIVERY SYSTEMS FOR ORAL DELIVERY OF POLYPHENOLS: A REVIEW
43. RECENT DEVELOPMENTS AND EMERGING TRENDS IN DRUG DISCOVERY
44. EXPLORING NEW APPLICATIONS OF EXISTING DRUGS IN CANCER THERAPY
45. INNOVATIONS IN NANOTECHNOLOGY FOR TARGETED DRUG DELIVERY IN CANCER PATIENTS
46. NANOTECHNOLOGY-STEERED APPROACHES IN THE FIELD OF PHYTOPHARMACEUTICALS: ENHANCED BIOAVAILABILITY, THERAPEUTIC VALUE AND SITE-SPECIFIC TARGETING
47. NANOMATERIALS: TYPES, CHARACTERIZATION METHODS, MECHANISMS AS ANTIMICROBIALS- A REVIEW
48. NANOMATERIAL AS ANTI-MALARIAL DRUG CARRIERS FOR THE EFFECTIVE TREATMENT OF MALARIA
49. COMPOSITE LRP AND VGG NETWORKS FOR BRAIN TUMOR ANALYSIS
50. VOL 2, CH 9: COMPARATIVE ANALYSIS OF CNN AND TRANSFORMER ARCHITECTURES FOR MELANOMA DETECTION USING DERMOSCOPIC IMAGES
51. VOL 2, CH 10: BIONANOCOMPOSITES IN ANTI-INFLAMMATORY ACTIVITY
52. VOL 2, CH 11: SCANDIUM-LABELED PET RADIOPHARMACEUTICALS IN RADIOTHERANOSTICS: PRECLINICAL INSIGHTS AND CLINICAL PERSPECTIVES
SECTION 2: ADVANCES IN VACCINES AND IMMUNOTHERAPIES
53. EMERGING VACCINE TECHNOLOGIES: REVOLUTIONIZING THE PREVENTION OF PANDEMICS
54. MRNA VACCINE TECHNOLOGY: THE NEW ERA OF INFECTIOUS DISEASE CONTROL AND CANCER IMMUNOTHERAPY
55. VACCINE-BASED THERAPEUTIC INTERVENTIONS IN UVEAL MELANOMA MANAGEMENT: A CONCEPTUAL REVIEW
56. EDIBLE VACCINES AND HUMAN HEALTH: REALITY AND PREDICTIONS
57. TYPHOID VACCINES: THE ROADWAY TO EFFECTIVE CONTROL
58. REWIRING THE IMMUNE SYSTEM: ROLE OF CAR-T CELLS IN CANCER TREATMENT
59. TUNING YAYS-NAYS FOR CHIMERIC ANTIGEN RECEPTOR BASED CANCER IMMUNOTHERAPY EFFICACY
SECTION 3 : FUNCTIONAL FOODS, NUTRITION, AND CHRONIC DISEASE MANAGEMENT
60. PALUDICULTURE: A SOURCE OF POLYPHENOLS FOR CLINICAL NUTRITION AND FAVOURABLE CARBON FOOTPRINT
61. SECONDARY METABOLITES LIKE FLAVONOIDS USED FOR CANCER TREATMENT: RECENT TRENDS AND FUTURE PERSPECTIVES
62. DEVELOPMENT OF PHYTOCHEMICAL-BASED FOOD PRODUCTS FOR THE PREVENTION AND MANAGEMENT OF CHRONIC DISEASES
63. THE FUTURE OF PROTEIN SECURITY: AN OVERVIEW OF POTENTIAL ALTERNATIVES TO NON-ANIMAL PROTEIN SOURCES
64. THE FARM-TO-FORK STRATEGY: FROM PRODUCTION AND MANUFACTURING TO SUSTAINABLE HEALTHYFOOD SUPPLY
65. THE FUTURE OF FOODS: ALTERNATIVE PROTEIN SOURCES
66. NUTRITIONAL AND THERAPEUTIC BENEFITS OF MILLETS IN HEALTH AND DISEASE: A SYSTEMATIC REVIEW FOR PREVENTING NON-COMMUNICABLE DISEASES
67. THE ROLE OF FUNCTIONAL FOODS, PLANT PROTEINS, AND OILSEEDS IN NUTRITIONAL STRATEGIES FOR DISEASE PREVENTION: AN OVERVIEW
68. PROBIOTICS FROM TRADITIONAL AND CLINICAL PROSPECTIVES
69. THE ROLE OF PROBIOTICS IN CANCER PREVENTION AND TREATMENT
SECTION 4 : MARINE AND MICROBIAL RESOURCES FOR HEALTH AND WELL-BEING
70. HARVESTING THE BOUNTY OF THE SEAS FOR SUSTAINABLE FOOD SUPPLY, DIETARY SUPPLEMENTS, NUTRACEUTICALS, AND MEDICINAL INGREDIENTS
71. GLOBALLY SUSTAINABLE PRODUCTS OF SEA ORIGIN FOR HEALTH PROMOTION AND DISEASE PREVENTION: AN OVERVIEW ON THE DISCOVERY OF MARINE-DERIVED FOODS AND NUTRACEUTICALS
SECTION 5 : HERBAL MEDICINE, NATURAL COMPOUNDS, AND INTEGRATIVE THERAPIES
72. HERBAL INTERVENTIONS FOR THE TREATMENT OF ALCOHOL ADDICTION
73. NATURAL PRODUCTS-BASED NIOSOMAL ANTI-CANCER FORMULATIONS: RECENT TRENDS AND FUTURE PERSPECTIVES
74. BIOLOGICAL ACTIVITIES OF ERIGERON ANNUS AND NERIUM INDICUM
75. BIOLOGICAL ACTIVITIES OF RUMEX NEPALENSIS AND HEDYCHIUM SPICATUM ERIGERON ANNUS AND NERIUM INDICUM
76. AN OVERVIEW OF THE PAST, PRESENT, AND FUTURE OF NATURAL ANTICANCER MEDICINES DERIVED FROM PLANTS AND MARINE SOURCES: EFFICACY, SAFETY, AND MECHANISMS
SECTION 1: BIOTECHNOLOGICAL INNOVATIONS FOR SUSTAINABLE DEVELOPMENT TOWARDS GOOD HEALTH CARE SYSTEM
1. ADVANCED TECHNOLOGIES FOR DISEASE INTERVENTION: INNOVATIONS ACROSS PRECISION MEDICINE
2. EMERGING APTAMER DIAGNOSTICS: NEXT GEN POINT-OF-CARE (POC) TECHNOLOGY
3. ROLE OF APTAMERS IN MOLECULAR MEDICINE
4. CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR) AND BEYOND: REVOLUTIONIZING PRECISION MEDICINE AND GENETIC THERAPIES
5. BIOSIMILARS IN CONTEMPORARY MEDICINE: FROM MOLECULAR DESIGN TO GLOBAL CLINICAL TRANSLATION
6. SWEET SITE OF RNA : DISCOVERY AND IMPLICATION OF GLYCO RNA IN HEALTH AND DISEASE
7. THE ROLE OF ER STRESS IN DISEASE AND IN THERAPEUTIC INTERACTION
SECTION 2: POTENTIAL OF STEM CELLS AND REGENERATIVE MEDICINE
8. ADULT STEM CELLS AND APPLICATIONS
9. EMBRYONIC STEM CELL RESEARCH: SCIENTIFIC ADVANCES AND BIOETHICAL CHALLENGES
10. ORGANOIDS AND LAB-GROWN TISSUES: A NEW FRONTIER IN DISEASE MODELING AND REGENERATIVE MEDICINE
11. 3D BIOPRINTING AND TISSUE ENGINEERING: BUILDING THE FUTURE OF TRANSPLANTATION
12. ADVANCEMENTS IN HUMAN-BASED BIOMATERIALS FOR 3D BIOPRINTING TECHNOLOGIES
13. POTENTIAL ROLE OF 3D-BIOPRINTING OF RECAPITULATED ORGANS AND TISSUES IN MODERN MEDICINE: AN OVERVIEW OF CARDIOVASCULAR DISEASES, CANCER, AND NON-CANCER APPLICATIONS
SECTION 3: ARTIFICIAL INTELLIGENCE & MACHINE LEARNING IN HEALTHCARE
14. ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN MICROBIAL DECIPHERING
15. ARTIFICIAL INTELLIGENCE IN CLINICAL DIAGNOSTICS AND DECISION MAKING
16. MODELING AND PREDICTING TO UNDERSTAND INFECTIOUS DISEASE TRANSMISSION
17. THE FUTURE OF HEALING: AI-DRIVEN PRECISION MEDICINE FOR PERSONALIZED HEALTH CARE
18. MOLECULAR EPIDEMIOLOGICAL APPROACH IN DISEASE MANAGEMENT
SECTION 4: MOLECULAR INSIGHTS AND ADVANCED THERAPEUTICS IN DISEASE MANAGEMENT
19. MAPPING MECHANISMS OF METASTASIS AND METABOLISM: ADVANCES IN UNDERSTANDING THE COMPLEXITY OF THETUMOR MICROENVIRONMENT
20. MOLECULAR PATHOPHYSIOLOGY OF STROKE: MECHANISTIC INSIGHTS, BIOMARKERS, AND EMERGING THERAPEUTIC TARGETS
21. PHARMACOTHERAPY OF HEART FAILURE: CURRENT TRENDS AND FUTURE DIRECTIONS
22. MOLECULAR INTERVENTIONS IN HEART FAILURE: GENE EDITING AND GENE THERAPY
23. ARRHYTHMIA-INDUCED SUDDEN CARDIAC DEATH: INSIGHTS AND PROSPECTS ON PATHOPHYSIOLOGY, BIOMARKERS, AND THERAPEUTIC STRATEGIES
24. ADVANCED STRATEGIES FOR DETECTION AND TREATMENT OF HIGH-RISK ATHEROSCLEROTIC PLAQUES: THE ROLE OF SINGLE-CELL RNA SEQUENCING
SECTION 5: NANOTECHNOLOGY AND BIOMATERIALS IN MODERN MEDICINE
25. PIONEERING ALZHEIMER'S DISEASE THERAPIES: INSIGHTS INTO PRECISION MEDICINE, NANOTHERAPEUTICS, AND STEM CELL INNOVATIONS
26. EVOLVING PARADIGMS IN ALZHEIMER'S DISEASE: FROM PATHOGENESIS TO PRECISION THERAPIES
SECTION 6: MICROBIOME, MENTAL HEALTH, AND INTEGRATIVE DISEASE MANAGEMENT
27. MICROBIOME MEDICINE: THE GUT-IMMUNE-BRAIN AXIS IN HEALTH AND DISEASE
28. THE CRUCIAL ROLES OF GUT MICROBIOTA IN THE DEVELOPMENT OF NON-COMMUNICABLE DISEASES WITH SPECIAL FOCUS ON THE EFFICACY OF PROBIOTICS AND BOVINE COLOSTRUM IN THE MANAGEMENT OF GASTROINTESTINAL DISORDERS IN ADULTS AND CHILDREN
29. THE PATHOPHYSIOLOGICAL RELATIONSHIP BETWEEN DIABETES MELLITUS AND ALZHEIMER’S DISEASE AND MANAGEMENT WITH HERBAL REMEDIES: AN OVERVIEW OF PRECLINICAL AND CLINICAL STUDIES.
30. EPIGENOME, NUTRIGENOME: IMPLICATIONS IN EVOLUTION OF TYPE 2 DIABETES
31. INSIGHTS INTO THE COMPLEXITIES OF DEMENTIA: DIAGNOSIS, THERAPEUTICS AND CURRENT RESEARCH
32. COGNITIVE DECLINE AND DEMENTIA IN ELDERLY HUMANS: HOLISTIC APPROACHES FOR THE PREVENTION AND MANAGEMENT OF NEURODEGENERATIVE DISEASES AND PSYCHIATRIC DISORDERS
33. REVOLUTIONIZING DENTAL CARE: A NEW ERA OF PRECISION, PERSONALIZATION, AND INNOVATION
34. OSTEOPOROSIS AS A PUBLIC HEALTH PROBLEM
35. INTEGRATIVE MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) THROUGH YOGIC INTERVENTIONS
36. CHALLENGES IN THE EARLY DIAGNOSIS OF RESPIRATORY DISEASES AND POSSIBLE INTERVENTIONS
37. PRECISION MEDICINE IN ACUTE AND CHRONIC PANCREATITIS
38. KIDNEY DISEASE – INNOVATIONS AND SOLUTIONS
39. PATHOPHYSIOLOGY OF CHRONIC KIDNEY DISEASE: EPIDEMIOLOGY, DIAGNOSTICBIOMARKERS, AND MANAGEMENT WITH PROBIOTICS AND PREBIOTICS
40. CURRENT TRENDS AND CHALLENGES IN REPRODUCTIVE HEALTH ACROSS GENDERS
41. MALE BREAST CANCER: RARELY KNOWN DISEASE
RANBIR C. SOBTI SR. AND JAGMOHAN SINGH
VOLUME 2: STRATEGIES FOR COMBATING DISEASES THROUGH NEW THERAPEUTICS, DRUG DEVELOPMENT, NUTRITIONAL APPROACHES, NUTRITION, AND HOLISTIC THERAPIES
SECTION 1: INNOVATIONS IN DRUG DISCOVERY, DELIVERY SYSTEMS, AND REPURPOSING
42. CARRAGEENAN AND FUCOIDAN-BASED DELIVERY SYSTEMS FOR ORAL DELIVERY OF POLYPHENOLS: A REVIEW
43. RECENT DEVELOPMENTS AND EMERGING TRENDS IN DRUG DISCOVERY
44. EXPLORING NEW APPLICATIONS OF EXISTING DRUGS IN CANCER THERAPY
45. INNOVATIONS IN NANOTECHNOLOGY FOR TARGETED DRUG DELIVERY IN CANCER PATIENTS
46. NANOTECHNOLOGY-STEERED APPROACHES IN THE FIELD OF PHYTOPHARMACEUTICALS: ENHANCED BIOAVAILABILITY, THERAPEUTIC VALUE AND SITE-SPECIFIC TARGETING
47. NANOMATERIALS: TYPES, CHARACTERIZATION METHODS, MECHANISMS AS ANTIMICROBIALS- A REVIEW
48. NANOMATERIAL AS ANTI-MALARIAL DRUG CARRIERS FOR THE EFFECTIVE TREATMENT OF MALARIA
49. COMPOSITE LRP AND VGG NETWORKS FOR BRAIN TUMOR ANALYSIS
50. VOL 2, CH 9: COMPARATIVE ANALYSIS OF CNN AND TRANSFORMER ARCHITECTURES FOR MELANOMA DETECTION USING DERMOSCOPIC IMAGES
51. VOL 2, CH 10: BIONANOCOMPOSITES IN ANTI-INFLAMMATORY ACTIVITY
52. VOL 2, CH 11: SCANDIUM-LABELED PET RADIOPHARMACEUTICALS IN RADIOTHERANOSTICS: PRECLINICAL INSIGHTS AND CLINICAL PERSPECTIVES
SECTION 2: ADVANCES IN VACCINES AND IMMUNOTHERAPIES
53. EMERGING VACCINE TECHNOLOGIES: REVOLUTIONIZING THE PREVENTION OF PANDEMICS
54. MRNA VACCINE TECHNOLOGY: THE NEW ERA OF INFECTIOUS DISEASE CONTROL AND CANCER IMMUNOTHERAPY
55. VACCINE-BASED THERAPEUTIC INTERVENTIONS IN UVEAL MELANOMA MANAGEMENT: A CONCEPTUAL REVIEW
56. EDIBLE VACCINES AND HUMAN HEALTH: REALITY AND PREDICTIONS
57. TYPHOID VACCINES: THE ROADWAY TO EFFECTIVE CONTROL
58. REWIRING THE IMMUNE SYSTEM: ROLE OF CAR-T CELLS IN CANCER TREATMENT
59. TUNING YAYS-NAYS FOR CHIMERIC ANTIGEN RECEPTOR BASED CANCER IMMUNOTHERAPY EFFICACY
SECTION 3 : FUNCTIONAL FOODS, NUTRITION, AND CHRONIC DISEASE MANAGEMENT
60. PALUDICULTURE: A SOURCE OF POLYPHENOLS FOR CLINICAL NUTRITION AND FAVOURABLE CARBON FOOTPRINT
61. SECONDARY METABOLITES LIKE FLAVONOIDS USED FOR CANCER TREATMENT: RECENT TRENDS AND FUTURE PERSPECTIVES
62. DEVELOPMENT OF PHYTOCHEMICAL-BASED FOOD PRODUCTS FOR THE PREVENTION AND MANAGEMENT OF CHRONIC DISEASES
63. THE FUTURE OF PROTEIN SECURITY: AN OVERVIEW OF POTENTIAL ALTERNATIVES TO NON-ANIMAL PROTEIN SOURCES
64. THE FARM-TO-FORK STRATEGY: FROM PRODUCTION AND MANUFACTURING TO SUSTAINABLE HEALTHYFOOD SUPPLY
65. THE FUTURE OF FOODS: ALTERNATIVE PROTEIN SOURCES
66. NUTRITIONAL AND THERAPEUTIC BENEFITS OF MILLETS IN HEALTH AND DISEASE: A SYSTEMATIC REVIEW FOR PREVENTING NON-COMMUNICABLE DISEASES
67. THE ROLE OF FUNCTIONAL FOODS, PLANT PROTEINS, AND OILSEEDS IN NUTRITIONAL STRATEGIES FOR DISEASE PREVENTION: AN OVERVIEW
68. PROBIOTICS FROM TRADITIONAL AND CLINICAL PROSPECTIVES
69. THE ROLE OF PROBIOTICS IN CANCER PREVENTION AND TREATMENT
SECTION 4 : MARINE AND MICROBIAL RESOURCES FOR HEALTH AND WELL-BEING
70. HARVESTING THE BOUNTY OF THE SEAS FOR SUSTAINABLE FOOD SUPPLY, DIETARY SUPPLEMENTS, NUTRACEUTICALS, AND MEDICINAL INGREDIENTS
71. GLOBALLY SUSTAINABLE PRODUCTS OF SEA ORIGIN FOR HEALTH PROMOTION AND DISEASE PREVENTION: AN OVERVIEW ON THE DISCOVERY OF MARINE-DERIVED FOODS AND NUTRACEUTICALS
SECTION 5 : HERBAL MEDICINE, NATURAL COMPOUNDS, AND INTEGRATIVE THERAPIES
72. HERBAL INTERVENTIONS FOR THE TREATMENT OF ALCOHOL ADDICTION
73. NATURAL PRODUCTS-BASED NIOSOMAL ANTI-CANCER FORMULATIONS: RECENT TRENDS AND FUTURE PERSPECTIVES
74. BIOLOGICAL ACTIVITIES OF ERIGERON ANNUS AND NERIUM INDICUM
75. BIOLOGICAL ACTIVITIES OF RUMEX NEPALENSIS AND HEDYCHIUM SPICATUM ERIGERON ANNUS AND NERIUM INDICUM
76. AN OVERVIEW OF THE PAST, PRESENT, AND FUTURE OF NATURAL ANTICANCER MEDICINES DERIVED FROM PLANTS AND MARINE SOURCES: EFFICACY, SAFETY, AND MECHANISMS
Product details
Product details
- Edition: 1
- Latest edition
- Published: October 1, 2026
- Language: English
About the editors
About the editors
RS
Ranbir Chander Sobti
Dr. Ranbir Chander (RC) Sobti is Emeritus Professor at Punjab University, Chandigarh, and Honorary Scientist at the Indian National Science Academy. He started his career as a cytogeneticist and progressed to molecular biology and disease processes of cancer, COPD, AIDS, metabolic syndrome, and kidney diseases. He is a Fellow of the Third World Academy of Sciences, National Academy of Sciences India, Indian National Science Academy, National Academy of Medical Sciences, National Academy of Agricultural Sciences, Canadian Academy of Cardiovascular Diseases Royal Society of biology and international Association of Cancer Research. Dr. Sobti has participated in several book projects, including Elsevier’s Advances in Animal Experimentation and Modeling; Biomarkers in Cancer Detection and Monitoring of Therapeutics; Molecular Medicine and Biomedical Research in the Era of Precision Medicine; One Planet, One Health, One Future; Probiotics; and Public and Environmental Health.
Affiliations and expertise
Professor (Emeritus), Department of Biotechnology, Panjab University, Chandigarh, IndiaAS
Aastha Sobti
Aastha Sobti is a Doctoral student at the Department of Immunotechnology at Lund University, Sweden. Her research areas interests include translational medicine, clinical dentistry, cancer immunology, biomarkers, diagnostics and medical oncology. Aastha Sobti has written two books with Elsevier: "Biomarkers in Cancer Detection and Monitoring of Therapeutics" (2023) and Molecular Medicine and Biomedical Research in the Era of Precision Medicine (2025).
Affiliations and expertise
Doctoral student, Department of Immunotechnology, Lund University, Lund, SwedenJS
Jagmohan Singh
Dr. Jagmohan Singh holds a Ph.D. in Biotechnology and Cancer Genomics from Punjab University, Chandigarh, India. He is currently serving as an adjunct faculty in Anatomy and Physiology at Thomas Jefferson University in Philadelphia, Pennsylvania. He has made significant contribution in Gastric Physiology and Pharmacology. His current research focus is on cancer immunotherapy and vaccine development against cancer recurrence. Dr. Singh's teaching and research experience has provided him with valuable insights into reviewing and editing scientific papers, review articles and book chapters, with diverse scientific aims. His research findings have been published in numerous internationally reputed journals. He has also made substantial contributions to cancer immunotherapy, including vaccine production, quality control, and clinical trials. As a multifaceted professional with a robust background in research, education, and administration, Dr. Singh’s contributions will be highly insightful to fulfilling the purpose of this book.
Affiliations and expertise
Department of Pharmacology Physiology and Cancer biology, Thomas Jefferson University Philadelphia, PA, USAHS
Harpal S. Buttar
Dr. Buttar has made valuable contributions to nanobiotechnology, phytomedicines, functional foods, clinical nutrition and prevention of cardiovascular diseases, obesity, and diabetes. In January 2014, the International Academy of Cardiovascular Sciences (India Section) established the "Dr. Harpal S. Buttar Oration Award" to recognize his leadership and contributions in promoting dietary and lifestyle changes in the prevention of cardiovascular diseases in Canada and around the world.
Based on his scientific accomplishments and distinguished contributions he was awarded Fellowships from the Punjab Academy of Sciences, International College of Nutrition, International Academy of Cardiovascular Sciences, and Indian Society of Pharmaceutical Education and Research. In 2019 the Society for Ethnopharmacology, India, gave the Special Recognition Award to Dr. Buttar for his outstanding contributions made in Phytomedicines and promotion of research in Pharmacology and Pharmaceutical Sciences.
He has authored / co-authored 56 book chapters, one monograph, and 158 research and review papers published in peer-reviewed journals.
Affiliations and expertise
Adjunct Professor, Department of Pathology and Laboratory Medicine University of Ottawa, Faculty of Medicine, Ottawa, Ontario, Canada